4
Changes in Ownership
INTERPACE BIOSCIENCES, INC. Filed Acc 0001493152-18-003187
Chief Commerical Officer acquired 28,000 shares (grant or award)
- Chief Commerical Officer acquired 2,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Richard Gregory Chief Commerical Officer | 2018-02-26 | Option exercise | +2,000 | 3,241 | D: show line 1 in the form | ||
| Richard Gregory Chief Commerical Officer | 2018-03-07 | Grant or award | +28,000 | 31,241 | D: show line 2 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Richard Gregory Chief Commerical Officer | 2018-02-26 | Option exercise · Restricted Stock Units | −2,000 | 2,000 | D: show line 3 in the form | ||
| Richard Gregory Chief Commerical Officer | 2018-03-07 | Grant or award · Stock Option (right to buy) | +112,000 | 112,000 | D: show line 4 in the form |
Loading xslF345X03/form4.xml…